133 related articles for article (PubMed ID: 38849640)
21. Dipeptidyl peptidase 3 plasma levels predict cardiogenic shock and mortality in acute coronary syndromes.
Wenzl FA; Bruno F; Kraler S; Klingenberg R; Akhmedov A; Ministrini S; Santos K; Godly K; Godly J; Niederseer D; Manka R; Bergmann A; Camici GG; von Eckardstein A; Stähli B; Muller O; Roffi M; Räber L; Lüscher TF
Eur Heart J; 2023 Oct; 44(38):3859-3871. PubMed ID: 37632743
[TBL] [Abstract][Full Text] [Related]
22. Hydrocortisone may act through the angiotensin II receptor-2 level in patients with catecholamine-resistant septic shock.
Baykan S; Bicakcioglu M; Bulut N; Yucel N; Ersoy Y; Kibrislioglu Uysal N; Ozer AB
Minerva Anestesiol; 2023 Apr; 89(4):298-305. PubMed ID: 36287393
[TBL] [Abstract][Full Text] [Related]
23. Circulating dipeptidyl peptidase-3 at admission is associated with circulatory failure, acute kidney injury and death in severely ill burn patients.
Dépret F; Amzallag J; Pollina A; Fayolle-Pivot L; Coutrot M; Chaussard M; Santos K; Hartmann O; Jully M; Fratani A; Oueslati H; Cupaciu A; Benyamina M; Guillemet L; Deniau B; Mebazaa A; Gayat E; Farny B; Textoris J; Legrand M;
Crit Care; 2020 Apr; 24(1):168. PubMed ID: 32321571
[TBL] [Abstract][Full Text] [Related]
24. Modulation of serum cytokine levels by a novel superoxide dismutase mimetic, M40401, in an Escherichia coli model of septic shock: correlation with preserved circulating catecholamines.
Macarthur H; Couri DM; Wilken GH; Westfall TC; Lechner AJ; Matuschak GM; Chen Z; Salvemini D
Crit Care Med; 2003 Jan; 31(1):237-45. PubMed ID: 12545022
[TBL] [Abstract][Full Text] [Related]
25. Sepsis Care Pathway 2019.
Labib A
Qatar Med J; 2019; 2019(2):4. PubMed ID: 31763206
[No Abstract] [Full Text] [Related]
26. Circulating dipeptidyl peptidase 3 on intensive care unit admission is a predictor of organ dysfunction and mortality.
Frigyesi A; Lengquist M; Spångfors M; Annborn M; Cronberg T; Nielsen N; Levin H; Friberg H
J Intensive Care; 2021 Aug; 9(1):52. PubMed ID: 34429159
[TBL] [Abstract][Full Text] [Related]
27. Angiotensin II treatment is associated with improved oxygenation in ARDS patients with refractory vasodilatory shock.
Leisman DE; Handisides DR; Chawla LS; Albertson TE; Busse LW; Boldt DW; Deane AM; Gong MN; Ham KR; Khanna AK; Ostermann M; McCurdy MT; Thompson BT; Tumlin JS; Adams CD; Hodges TN; Bellomo R
Ann Intensive Care; 2023 Dec; 13(1):128. PubMed ID: 38103056
[TBL] [Abstract][Full Text] [Related]
28. [Comparative study of dexmedetomidine vs. midazolam on plasma catecholamine levels and hemodynamics in patients with septic shock].
Yao L; Liu B; He T; Shen F
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2021 Oct; 33(10):1193-1197. PubMed ID: 34955127
[TBL] [Abstract][Full Text] [Related]
29. In-hospital mortality and organ failure after open and endovascular thoraco-abdominal aortic surgery can be predicted by increased levels of circulating dipeptidyl peptidase 3.
Gombert A; Barbati M; Kotelis D; Simon TP; Breuer T; Hartmann O; Santos K; Bergmann D; Schulte J; Marx G; Jacobs M; Stoppe C
Eur J Cardiothorac Surg; 2021 Apr; 59(4):750-757. PubMed ID: 33236058
[TBL] [Abstract][Full Text] [Related]
30. Dipeptidyl peptidase 3 modulates the renin-angiotensin system in mice.
Jha S; Taschler U; Domenig O; Poglitsch M; Bourgeois B; Pollheimer M; Pusch LM; Malovan G; Frank S; Madl T; Gruber K; Zimmermann R; Macheroux P
J Biol Chem; 2020 Oct; 295(40):13711-13723. PubMed ID: 32546481
[TBL] [Abstract][Full Text] [Related]
31. [Effects of treatment based on different target mean arterial pressure on gastrointestinal function in septic shock patients with hypertension].
Zhu X; Hou J; Zhang Q; Wei S; Cai T; Lyu G; Wang X
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2021 May; 33(5):517-522. PubMed ID: 34112285
[TBL] [Abstract][Full Text] [Related]
32. Sublingual microcirculatory effects of enalaprilat in an ovine model of septic shock.
Salgado DR; He X; Su F; de Sousa DB; Penaccini L; Maciel LK; Taccone F; Rocco JR; Silva E; De Backer D; Vincent JL
Shock; 2011 Jun; 35(6):542-9. PubMed ID: 21283060
[TBL] [Abstract][Full Text] [Related]
33. High Circulating Dipeptidyl Peptidase 3 Predicts Mortality and Need for Organ Support in Cardiogenic Shock: An Ancillary Analysis of the ACCOST-HH Trial.
Picod A; Nordin H; Jarczak D; Zeller T; Oddos C; Santos K; Hartmann O; Herpain A; Mebazaa A; Kluge S; Azibani F; Karakas M
J Card Fail; 2024 Apr; ():. PubMed ID: 38697465
[TBL] [Abstract][Full Text] [Related]
34. Promotion of vascular integrity in sepsis through modulation of bioactive adrenomedullin and dipeptidyl peptidase 3.
van Lier D; Kox M; Pickkers P
J Intern Med; 2021 Jun; 289(6):792-806. PubMed ID: 33381880
[TBL] [Abstract][Full Text] [Related]
35. Comparison of cardiac, hepatic, and renal effects of arginine vasopressin and noradrenaline during porcine fecal peritonitis: a randomized controlled trial.
Simon F; Giudici R; Scheuerle A; Gröger M; Asfar P; Vogt JA; Wachter U; Ploner F; Georgieff M; Möller P; Laporte R; Radermacher P; Calzia E; Hauser B
Crit Care; 2009; 13(4):R113. PubMed ID: 19591694
[TBL] [Abstract][Full Text] [Related]
36. Angiotensin II in septic shock.
Jadhav AP; Sadaka FG
Am J Emerg Med; 2019 Jun; 37(6):1169-1174. PubMed ID: 30935784
[TBL] [Abstract][Full Text] [Related]
37. [Effect of global end diastolic volume index guidance fluid resuscitation in elderly patients with septic shock].
Ma S; Zhang R; Wang S; Zhao M; Wang L; Zhang Y
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2017 Jun; 29(6):486-490. PubMed ID: 28625234
[TBL] [Abstract][Full Text] [Related]
38. MicroRNA-155 Amplifies Nitric Oxide/cGMP Signaling and Impairs Vascular Angiotensin II Reactivity in Septic Shock.
Vasques-Nóvoa F; Laundos TL; Cerqueira RJ; Quina-Rodrigues C; Soares-Dos-Reis R; Baganha F; Ribeiro S; Mendonça L; Gonçalves F; Reguenga C; Verhesen W; Carneiro F; Paiva JA; Schroen B; Castro-Chaves P; Pinto-do-Ó P; Nascimento DS; Heymans S; Leite-Moreira AF; Roncon-Albuquerque R
Crit Care Med; 2018 Sep; 46(9):e945-e954. PubMed ID: 29979224
[TBL] [Abstract][Full Text] [Related]
39. Continuous terlipressin versus vasopressin infusion in septic shock (TERLIVAP): a randomized, controlled pilot study.
Morelli A; Ertmer C; Rehberg S; Lange M; Orecchioni A; Cecchini V; Bachetoni A; D'Alessandro M; Van Aken H; Pietropaoli P; Westphal M
Crit Care; 2009; 13(4):R130. PubMed ID: 19664253
[TBL] [Abstract][Full Text] [Related]
40. Broad spectrum vasopressors: a new approach to the initial management of septic shock?
Chawla LS; Ostermann M; Forni L; Tidmarsh GF
Crit Care; 2019 Apr; 23(1):124. PubMed ID: 30992045
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
